Epidemiological survey of the lung lesions associated to Mycoplasma hyopneumoniae at the slaughterhouse in pigs vaccinated with dierent Mhyo vaccines in Spain



The assessment of lung lesions compatible with Enzootic Pneumonia (EN) at  the slaughterhouse is the reference technique for assessing the effectiveness  of vaccines against Mycoplasma hyopneumoniae (Mhyo). However, control of  EN and so the result, may depend also on other factors like concomitant  disease involved on the porcine respiratory disease complex (PRDC),  environment conditions or management1,2.
The aim of the study was to assess the EN-like lesions from pigs coming from  farms using different vaccination Mhyo vaccines in Spain.

Materials & methods

30 positive Mhyo farms from the North-east of Spain, were randomly selected.
Total amounts of 6,119 lungs were checked individually at different  slaughterhouses. 19 farms (3,677 lungs) were using Mhyosphere® PCV ID  (vaccine A), a new intradermal needle-free vaccine against Mhyo and  PCV2-associated disease all in one, 6 farms (1,412 lungs) were using vaccine  B, an intramuscular vaccine against Mhyo/PCV2 all in one, and 5 farms (1,030  lungs) were using vaccine C, an intramuscular vaccine against Mhyo. The
study was done simultaneously between September to December 2021.

All lungs were evaluated individually at the slaughterhouse following the  MADEC modified method3, with an observer-blinded system, so that, the  observer didn’t know which vaccine was evaluating.

For each farm, the incidence (percentage of lungs with lesion), disease index  (average lesion grade of all lungs), lesion index (average lesion grade of  affected lungs), and % of lung surface affected was evaluated and compared  statistically amongst different vaccines. The extra cost per pig was also  assessed according to the grade of lesion and the reference of Straw et al.4


The incidence of EN was statistically significantly lower in farms vaccinating
with vaccine A (28.31%) compared to farms using vaccine B (50.4%, p=0.03)
and vaccine C (52.7%, p=0.04).

The disease index was significantly lower in farms vaccinating with vaccine A  (0.46) compared to farms using vaccine B (0.91, p=0.03) and Vaccine C (1.15,  p=0.05).

The distribution of the lung lesion grades (Figure 1) was different between  vaccines, with higher percentage of animals without lesion (grade 0) with  Vaccine A (Mhyosphere® PCV ID), which consequently affected the extra  cost/pig (Table 1) being more than 2 € per pig with Vaccine B and C, and 1,10  € with Vaccine A.

Discussion and Conclusion

The farms vaccinated with Mhyosphere® PCV ID had significant lower  incidence and disease index of EN compared to farms using other commercial  vaccines. This study may suggest stronger Mhyo control in farms using this  vaccine; however, other factor like environment, concomitant diseases or  management should be also considered in future studies.


The authors wish to thank PROVETSA for their support and technical  assistance during the trial.


1. Pieters M. and Maes D. Chapter Mycoplasmosis (863-883) Diseases of Swine,  Eleventh Edition. Edited by Jeffrey J. Zimmerman et al. (2019) John Wiley &  Sons, Inc. Published 2019 by John Wiley & Sons, Inc.

2. Christensen G, Sorensen V, Mousing J (1999) Diseases of the respiratory  system. In: Diseases of Swine, 8th Edit., B Straw, SD ‘Allaire, W Mengeling, DJ  Taylor, Eds., Iowa State University Press, Ames, pp. 913e940.

3. Madec F, Kobisch M (1982) Bilan lesionnel des poumons de porcs charcutiers  à l’abattoir [Assessment of lung lesions in fattening pigs at the slaughterhouse].  Journees de la Recherche Porcine [Swine Research Conference], 14, 405e412.

4. Straw BE, Tuovinen VK, Bigras-Poulin M. Estimation of the cost of pneumonia  in swine herds. J Am Vet Med Assoc. 1989 Dec 15;195(12):1702–1706.